[go: up one dir, main page]

WO2008119097A8 - Pharmaceutical substance for itching and pain - Google Patents

Pharmaceutical substance for itching and pain

Info

Publication number
WO2008119097A8
WO2008119097A8 PCT/AT2008/000120 AT2008000120W WO2008119097A8 WO 2008119097 A8 WO2008119097 A8 WO 2008119097A8 AT 2008000120 W AT2008000120 W AT 2008000120W WO 2008119097 A8 WO2008119097 A8 WO 2008119097A8
Authority
WO
WIPO (PCT)
Prior art keywords
itching
pain
pharmaceutical substance
salvinorin
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/AT2008/000120
Other languages
German (de)
French (fr)
Other versions
WO2008119097A1 (en
Inventor
Andreas Kubin
Angelika Bodenteich
Georg Jessner
Josef Boeckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Planta Naturstoffe Vertriebsgesmbh
PLANTA NATURSTOFFE VERTRIEBSGE
Original Assignee
Planta Naturstoffe Vertriebsgesmbh
PLANTA NATURSTOFFE VERTRIEBSGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Planta Naturstoffe Vertriebsgesmbh, PLANTA NATURSTOFFE VERTRIEBSGE filed Critical Planta Naturstoffe Vertriebsgesmbh
Publication of WO2008119097A1 publication Critical patent/WO2008119097A1/en
Publication of WO2008119097A8 publication Critical patent/WO2008119097A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to the use of Salvinorin or Salvia divinorum for producing a pharmaceutical composition for the topical treatment of itching or pain, a medication comprising the same, and the production thereof.
PCT/AT2008/000120 2007-04-02 2008-04-02 Pharmaceutical substance for itching and pain Ceased WO2008119097A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ATA516/2007 2007-04-02
AT0051607A AT505086B1 (en) 2007-04-02 2007-04-02 PHARMACEUTICAL AGENT AGAINST JUCKREIZ AND JUCKREIZED PAIN

Publications (2)

Publication Number Publication Date
WO2008119097A1 WO2008119097A1 (en) 2008-10-09
WO2008119097A8 true WO2008119097A8 (en) 2008-12-11

Family

ID=39402846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AT2008/000120 Ceased WO2008119097A1 (en) 2007-04-02 2008-04-02 Pharmaceutical substance for itching and pain

Country Status (2)

Country Link
AT (1) AT505086B1 (en)
WO (1) WO2008119097A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646814C2 (en) * 2016-07-26 2018-03-07 Вадим Степанович Дмитрук Method of lichen planus treatment

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103313601B (en) 2010-06-29 2015-04-08 宾夕法尼亚大学理事会 Salvinorin compositions and uses thereof
US11000505B2 (en) 2010-06-29 2021-05-11 The Trustees Of The University Of Pennsylvania Salvinorin compositions and uses thereof
RU2510269C2 (en) * 2011-03-09 2014-03-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Method of treating lichen acuminatus in oral mucosa
JP2017508768A (en) 2014-03-21 2017-03-30 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア Salvinorin compositions and uses thereof
WO2018231618A1 (en) * 2017-06-14 2018-12-20 The Scripps Research Institute Synthesis of 20-nor-salvinorin a
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
CN113993522A (en) 2019-04-17 2022-01-28 指南针探路者有限公司 Method for treating anxiety disorders, headache disorders and eating disorders with siloxibin
TW202408484A (en) * 2022-06-27 2024-03-01 合一生技股份有限公司 Plectranthus amboinicus extract for use in alleviation of radiation-induced skin disorders
CN116785270A (en) * 2023-05-10 2023-09-22 上海大学 Application of sodium salvianic acid A in preparation of medicine and health-care product for treating chronic pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10231073A1 (en) * 2002-07-10 2004-01-22 Lührmann, Marianne Liniment for rapid alleviation of eczema and neurodermatitis, comprising extract of sage leaves in ointment base
US20040191334A1 (en) * 2003-03-24 2004-09-30 Pang-Chui Shaw Use of transhinone derivates as cholinesterase inhibitors in treating related diseases
CA2559207A1 (en) * 2004-03-12 2005-09-29 The Mclean Hospital Corporation Salvinorin derivatives and uses thereof
EP1809104A4 (en) * 2004-09-23 2009-04-29 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2646814C2 (en) * 2016-07-26 2018-03-07 Вадим Степанович Дмитрук Method of lichen planus treatment

Also Published As

Publication number Publication date
AT505086A1 (en) 2008-10-15
AT505086B1 (en) 2009-06-15
WO2008119097A1 (en) 2008-10-09

Similar Documents

Publication Publication Date Title
WO2008119097A8 (en) Pharmaceutical substance for itching and pain
WO2008046581A3 (en) Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
MX2010006033A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof.
WO2009068214A3 (en) Heteroaryl-substituted piperidines
WO2007081949A3 (en) Small-volume oral transmucosal dosage forms
WO2009124266A3 (en) Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof
WO2007113558A8 (en) Quinazolinone derivatives having b-raf inhibitory activity
EP4327867A3 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
WO2009121039A3 (en) Administration of benzodiazepine compositions
IL204052A (en) 1,1,1- trifluoro-2- hydroxy-3- phenylpropane derivatives, process for their manufacture, pharmaceutical compositions comprising the same and uses thereof for the preparation of medicaments
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
TNSN08284A1 (en) Masking the taste of powders
WO2007131047A3 (en) Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
WO2011023367A3 (en) Bisphosphonate-prodrugs
WO2011058245A8 (en) Novel mannopyranoside derivatives with anticancer activity
PL2244703T3 (en) The drug, its manufacture and use in the treatment of painful neuropathies
CL2008000982A1 (en) COMPOUNDS DERIVED FROM 5-OXO-ISOXAZOL-CARBOXAMIDA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION; PROCEDURE OF PRODUCTION OF THE PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND / OR PREVENTION OF ATEROSCLEROTIC DISORDERS, OF METABOLISM OF
WO2009080745A3 (en) Perhydroquinoxaline derivatives as analgesics
WO2008094054A3 (en) 6, 8-dichlorchroman-3-yl-l, 3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders
WO2008037937A3 (en) Use of compounds of the milbemycin family for the treatment of dermatological disorders in human beings
WO2009077635A3 (en) Anti-inflammatory, anti-edematous and anti-erythematous composition, method for obtaining same and use thereof
WO2008063311A3 (en) Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08733225

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08733225

Country of ref document: EP

Kind code of ref document: A1